With FDA approval, resmetirom, a liver-targeted thyroid hormone receptor- (THR) selective agonist, changes the MASH drug development landscape
[16] [18] The trial exclusion criteria for retatrutide reflect a similar precautionary approach and should not be interpreted as a confirmed risk in humans
Adherence to a Mediterranean diet was associated with a lower risk of cognitive impairment in a major new study, but only one food within that diet -- fish -- was also linked to slower loss of cognitive function
HOW IT WORKS A brain-based approach
These advanced formulations reduce side effects and improve the overall treatment experience
To maximize safety: use only high-quality, sterile compounding, follow dosing protocols strictly, and ensure professional oversight